PHA — Premier Health of America Share Price
- CA$4.44m
- CA$56.23m
- CA$158.19m
- 64
- 82
- 11
- 52
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 2.4 | ||
Price to Tang. Book | n/a | ||
Price to Free Cashflow | 1.21 | ||
Price to Sales | 0.03 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -59.67% | ||
Return on Equity | -160.58% | ||
Operating Margin | -5.44% |
Financial Summary
Year End 30th Sep | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | CA$m | 20.74 | 66.63 | 80.51 | 90.39 | 158.19 | 129.91 | 130.25 | 68.58% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | +129.31 | +11.71 | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Premier Health of America Inc. is a Canadian healthtech company. The Company provides a comprehensive range of outsourced service solutions for healthcare needs to governments, corporations, and individuals. The Company uses its proprietary LiPHe platform to lead the healthcare services sector in digital transformation to provide patients with more accessible care services. The Company operates through two segments: Per Diem and Travel Nurses. The Per Diem segment includes Premier Soin and Code Bleu, two of its Quebec subsidiaries that offer their respective services for nursing and assistance by profile and by region. The Travel nurse segment includes Canadian Health Care Agency, Premier Soin Nordik, Solutions Nursing as well as Solutions Staffing, four of its subsidiaries that offer their respective services to the federal and provincial governments for nursing and assistance, including in remote regions.
Directors
- Last Annual
- September 30th, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- July 13th, 2017
- Public Since
- December 24th, 2018
- No. of Employees
- 555
- Sector
- Software & IT Services
- Industry
- Technology
- Exchange
TSX Venture Exchange
- Shares in Issue
- 55,514,151

- Address
- 1114 Cure-Labelle Blvd., Suite 01, BLAINVILLE, J7C 2M9
- Web
- https://www.premierhealthgroup.ca/
- Phone
- +1 5143976946
- Auditors
- Raymond Chabot Grant Thornton LLP
Upcoming Events for PHA
Q3 2025 Premier Health of America Inc Earnings Release
Similar to PHA
01 Communique Laboratory
TSX Venture Exchange
Acceleware
TSX Venture Exchange
AGEDB Technology
TSX Venture Exchange
Aisix Solutions
TSX Venture Exchange
AnalytixInsight
TSX Venture Exchange
FAQ
As of Today at 04:44 UTC, shares in Premier Health of America are trading at CA$0.08. This share price information is delayed by 15 minutes.
Shares in Premier Health of America last closed at CA$0.08 and the price had moved by -83.33% over the past 365 days. In terms of relative price strength the Premier Health of America share price has underperformed the Toronto Stock Exchange 300 Composite Index by -85.18% over the past year.
The overall consensus recommendation for Premier Health of America is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out morePremier Health of America does not currently pay a dividend.
Premier Health of America does not currently pay a dividend.
Premier Health of America does not currently pay a dividend.
To buy shares in Premier Health of America you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of CA$0.08, shares in Premier Health of America had a market capitalisation of CA$4.44m.
Here are the trading details for Premier Health of America:
- Country of listing: Canada
- Exchange: CVE
- Ticker Symbol: PHA
Based on an overall assessment of its quality, value and momentum Premier Health of America is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Premier Health of America is CA$0.20. That is 150% above the last closing price of CA$0.08.
Analysts covering Premier Health of America currently have a consensus Earnings Per Share (EPS) forecast of -CA$0.12 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Premier Health of America. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -58.14%.
As of the last closing price of CA$0.08, shares in Premier Health of America were trading -60.64% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Premier Health of America PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$0.08.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Premier Health of America's directors